Overview
- Simo announced on Thursday that she will not return to full-time work after a severe exacerbation of a chronic illness and will shift to a part-time advisory role to focus on recovery.
- She has long disclosed a diagnosis of postural orthostatic tachycardia syndrome, or POTS, and first went on medical leave in April when her condition worsened.
- While Simo was on leave, OpenAI redistributed her product and business duties to senior leaders including Greg Brockman, CFO Sarah Friar and Chief Strategy Officer Jason Kwon.
- The announcement coincided with OpenAI’s largest ChatGPT update to date, which added an AI agent that can take actions for users such as moving local files and writing code as part of a unified agentic ‘superapp’ effort.
- OpenAI confidentially filed IPO paperwork in early June and Simo’s departure sharpens investor focus on succession, governance and whether leadership changes will affect the company’s product rollout and timing or valuation of a public listing.